Lois PrivorDumm is an expert in the field of vaccine introduction  She is especially recognized for her work with new vaccine introduction which has included strategies to accelerate access in lowincome country
She has worked with countries in all income groups and has leveraged her experiences in high and middle income countries to contribute to the significant recent improvements in access in low and lowmiddle income countries She currently serves as the Director of Alliances & Information at the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health Her  team conducts advocacy and communications for child health coordination of the World Pneumonia Day Coalition and working with large countries such as India and Nigeria to provide technical assistance in the form of advocacy and communications evidence synthesis stakeholder mapping and research to help countries develop strategies to address the barriers to decision making and implementation for new vaccines

Her team has worked closely with a variety of stakeholders in India and Nigeria and is focused on building both highlevel political and grassroots support She is currently leading projects in India and Nigeria made possible through grants from the GAVI Alliance and Bill & Melinda Gates Foundation

She is a member of the GAVI Large Country Task Team and the PDP Access Steering Committee and has worked on a number of access related projects dealing with economics and financing supply distribution and demand forecasting in addition to her work with advocacy communications and policy

Background and education
Ms PrivorDumm holds an International MBA (IMBA) formerly Masters in International Business (MIBS) from the University of South Carolina and completed her studies and internship in Brussels Belgium She completed her undergraduate studies at the University at Albany in Business Administration (Finance) and Spanish

Early career
Ms PrivorDumm spent years in the vaccine industry working for Wyeth where she helped lead efforts to launch Prevnar (pneumococcal conjugate vaccine) in the US achieving unprecedented uptake of a new pediatric vaccine  Following the successful US experience she worked as Commercial Director for the Latin American countries to introduce pneumococcal and meningococcal vaccines  Later she worked as Senior Director for Commercial Operations in Europe the Middle East and Africa providing guidance to countries to build awareness about Wyeths vaccines and pharmaceuticals in the scientific community supporting efforts with policy makers regarding the introduction of new vaccines and providing marketing and operational expertise to support ongoing business  She also worked at GlaxoSmithkline as director for global commercial strategy for various projects

Johns Hopkins Bloomberg School of Public Health
In 2005 she joined The Johns Hopkins Bloomberg School of Public Health to lead Communications & Strategy for the Hib Initiative a GAVIfunded project with an aim to accelerate and sustain decisions regarding Hib vaccines to help prevent meningitis and pneumonia in children Now serving as Director of Alliances and Information for IVAC she has been cited as an expert for different global vaccine campaigns and been involved in research and promotion of vaccine awareness She has been interviewed by Developments Magazine and African Press International about the availability of pneumonia related vaccines in African countries

Ms PrivorDumm has also worked on different communication tools regarding the availability of vaccines in developing countries in order to raise awareness about the value of pneumococcal and Hib vaccinations to prevent pneumonia and reach Millennium Development Goals 4 by 2015

Research

AVITAC
The mission of the Accelerated Vaccine Introduction Initiative (AVI) is to save lives prevent disease and promote health through timely and equitable access to new and underused
vaccines Together AVI partners serve to:
 Empower countries to make evidencebased decisions on new and underused vaccines
 Support successful country introduction and sustained use of new and underused vaccines
 Contribute analyses and assess impact of GAVI Alliance (GAVI) policies that influence accelerated introduction of new and underused vaccines
 Ensure sufficient supply of new and underused vaccines of assured quality and meeting  programmatic needs of developing countries

The Accelerated Vaccine Initiative Technical Advisory Consortium (AVI TAC) supports the achievement of AVI objectives through its leadership in creating the evidence base advocating for evidencedriven decisionmaking and building platform capacity that can be used to accelerate the introduction of future vaccines

Publications
 
 
 
 
 http://wwwprborg/Articles/2006/HibVaccineCouldReduceMajorChildhoodDiseasesaspx Hib Vaccine Could Reduce Major Childhood Diseases
 http://wwwdisruptivewomennet/author/lprivordumm/ Getting lifesaving vaccines to those who need it most: the nuanced solution for access
 https://webarchiveorg/web/20091128031402/http://wwwhsphharvardedu/pgda/Working%20Papers/2009/PGDA_WP_45pdf The Economic Case for Expanding Vaccination Coverage of Children
 http://wwwdisruptivewomennet/author/lprivordumm/ What Happiness Looks Like: A Chance for Change on World Pneumonia Day

References




